Copyright © 2023 Bain & Company, Inc. All rights reserved.
This work is based on secondary market research, analysis of inancial information available or provided to Bain & Company and a range of
interviews with industry participants. Bain & Company has not independently veriied any such information provided or available to Bain
and makes no representation or warranty, express or implied, that such information is accurate or complete. Projected market and inancial
information, analyses and conclusions contained herein are based on the information described above and on Bain & Company’s judgment,
and should not be construed as deinitive forecasts or guarantees of future performance or results. The information and analysis herein does
not constitute advice of any kind, is not intended to be used for investment purposes, and neither Bain & Company nor any of its subsidiaries
or their respective oicers, directors, shareholders, employees or agents accept any responsibility or liability with respect to the use of
or reliance on any information or analysis contained in this document. This work is copyright Bain & Company and may not be published,
transmitted, broadcast, copied, reproduced or reprinted in whole or in part without the explicit written permission of Bain & Company.
Acknowledgments
This report was prepared by Bain’s Global Healthcare Private Equity practice and a team led by
Samantha Gorang, an associate partner in Atlanta; Peter Accomando, a senior manager in Boston; and
John Day, Americas Healthcare Private Equity practice director. The authors thank Olivia Pavco Giaccia,
Dela Kpo, Javon Tai, James Porter, Robert Schrettl, and Samantha Tralka for their contributions;
John Campbell and Robert Rosenberg for their editorial leadership; and Emily Lane, John Peverley,
and Laura Caringella for their research assistance. We’re grateful to Dealogic, AVCJ, S&P Capital IQ,
Preqin, and DealEdge® for the valuable data they provided for this report.